Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.50 |
| ▸ | MEN1 | O00255 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.47 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | CRHBP | P24387 | 1/20 | 0.45 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.45 |
| ▸ | LCK | P06239 | 1/20 | 0.45 |
| ▸ | PPARD | Q03181 | 1/20 | 0.45 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.45 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.45 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7508355 | 1.00 | TDP1 (0.50) | TDP1MEN1KMT2AZDHHC7L3MBTL1 | |
| SCHEMBL7775862 | 1.00 | TDP1 (0.50) | TDP1MEN1KMT2AZDHHC7L3MBTL1 | |
| SCHEMBL5860379 | 1.00 | TDP1 (0.50) | TDP1MEN1KMT2AZDHHC7L3MBTL1 | |
| SCHEMBL10017368 | 1.00 | TDP1 (0.50) | TDP1MEN1KMT2AZDHHC7L3MBTL1 | |
| SCHEMBL2948251 | 1.00 | TDP1 (0.50) | TDP1MEN1KMT2AZDHHC7L3MBTL1 | |
| SCHEMBL4416096 | 1.00 | TDP1 (0.50) | TDP1MEN1KMT2AZDHHC7L3MBTL1 | |
| SCHEMBL6828633 | 1.00 | TDP1 (0.50) | TDP1MEN1KMT2AZDHHC7L3MBTL1 | |
| SCHEMBL9116048 | 1.00 | TDP1 (0.50) | TDP1MEN1KMT2AZDHHC7L3MBTL1 | |
| SCHEMBL182928 | 1.00 | TDP1 (0.50) | TDP1MEN1KMT2AZDHHC7L3MBTL1 | |
| SCHEMBL1433359 | 1.00 | TDP1 (0.50) | TDP1MEN1KMT2AZDHHC7L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10647738-B2 | Xylene-based amphiphilic compound and use thereof | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION (KR) | 2020-05-12 | — | — | US | disclosed |
| US-20180273570-A1 | NOVEL XYLENE-BASED AMPHIPHILIC COMPOUND AND USE THEREOF | INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) | 2018-09-27 | — | — | US | disclosed |
| WO-2017039107-A1 | NEW XYLENE-BASED AMPHIPATHIC COMPOUND AND USE THEREOF | 한양대학교 에리카산학협력단 | 2017-03-09 | — | — | WO | disclosed |
| CN-105287363-A | Micromolecular organic gel for orthotopic injection and preparation method and application thereof | GANNAN NORMAL UNIVERSITY | 2016-02-03 | — | — | CN | disclosed |
| US-7078159-B2 | Method for the preparation of a printing plate | EASTMAN KODAK COMPANY (US) | 2006-07-18 | — | — | US | disclosed |
| EP-1386729-A1 | Method for the preparation of a printing plate | EASTMAN KODAK COMPANY (US) | 2004-02-04 | — | — | EP | disclosed |
| US-20040018447-A1 | Method for the preparation of a printing plate | EASTMAN KODAK COMPANY | 2004-01-29 | — | — | US | disclosed |
| EP-0121088-B1 | NEW O-ACYL-ALKANEDIOL-PHOSPHOLIPIDS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | A. Nattermann & Cie. GmbH (DE) | 1986-10-01 | — | — | EP | disclosed |
| US-4610979-A | O-acyl-alkanediol-phospholipids and processes for the treatment of asthma | A. NATTERMANN & CIE GMBH (DE) | 1986-09-09 | — | — | US | disclosed |
| EP-0121088-A1 | New o-acyl-alkanediol-phospholipids, processes for their preparation and pharmaceutical preparations containing them | A. Nattermann & Cie. GmbH (DE) | 1984-10-10 | — | — | EP | disclosed |
| EP-0112344-A1 | AMPHIPATHIC COMPOUNDS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1984-07-04 | — | — | EP | disclosed |
| WO-1983004412-A1 | AMPHIPATHIC COMPOUNDS | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1983-12-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180273570-A1 | NOVEL XYLENE-BASED AMPHIPHILIC COMPOUND AND USE THEREOF | PEX14, SLC47A2, PXMP4 | TDP1 3894/4885MEN1 3834/4885KMT2A 3018/4885 |
| US-10647738-B2 | Xylene-based amphiphilic compound and use thereof | PEX14, PXMP4, SLC47A2 | TDP1 3714/4885MEN1 3487/4885KMT2A 2850/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.